Stocks making the biggest moves after hours: FedEx, First Republic Bank and more | | StockXpo

Try Stockxpo Premium

Stocks making the biggest moves after hours: FedEx, First Republic Bank and more

Published: Thursday, March 16, 2023 · 9:01 PM  |  Updated: Thursday, March 16, 2023 · 9:01 PM

📊 4,153 views

SHARE

Twitter


Facebook


LinkedIn


Email

🗝️ Key Points

  • A worker sorts packages at a FedEx Express facility on Cyber Monday in Garden City, New York, US, on Monday, Nov.
  • 28, 2022.Michael Nagle | Bloomberg | Getty ImagesCheck out the Companies making headlines in extended trading.FedEx — The package-shipping company's shares were up 9% after.
  • FedEx reported adjusted earnings of $3.41 per share, topping analysts' estimates of $2.73 per share, according to Refinitiv.

A worker sorts packages at a FedEx Express facility on Cyber Monday in Garden City, New York, US, on Monday, Nov. 28, 2022.

Michael Nagle | Bloomberg | Getty Images

Check out the companies making headlines in extended trading.

FedEx — The package-shipping company’s shares were up 9% after it reported a beat on earnings in its fiscal third quarter and raised its earnings forecast for the full year. FedEx reported adjusted earnings of $3.41 per share, topping analysts’ estimates of $2.73 per share, according to Refinitiv. Meanwhile, the company’s revenue fell below expectations. FedEx posted $22.17 billion in revenue, while analysts had estimated $22.74 billion. Shares of United Parcel Service popped 2% in sympathy.

First Republic Bank — The bank’s shares were down 15% during after-hours trading. During the regular trading session, the stock reversed earlier losses and rallied almost 10% as a group of 11 banks, including Bank of America and Goldman Sachs, agreed to deposit $30 billion in First Republic. Shares of Zions Bancorp and KeyCorp, which are among the regional banks facing a rough week, fell more than 2%.

Merck — Shares of the pharmaceutical company fell nearly 2% in extended trading after Merck provided an update on a trial for one of its metastatic non-small cell lung cancer drugs. The results didn’t reach “statistical significance,” and Merck said patients in this arm of the study “should be switched to a standard of care.”

Source

MORE IN INSIDE FINANCE

Reportedly-zeroing-in-on-suspicious-trades-ahead-of-market-moving-trump-post/" style="text-decoration: none; color: inherit;">

Regulators are reportedly zeroing in on suspicious trades ahead of market-moving Trump post

Published: Wednesday, April 15, 2026 · 7:06 PM

Leave a Reply

Your email address will not be published. Required fields are marked *

scroll to top